Sort
30,917 grants matching “tumor microenvironment”
TGF Beta Signals in Prostate Stromal-Epithelial Interactions
$355,099Neil A Bhowmick · Cedars-Sinai Medical Center · R01 · FY2014 · CA
Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis
$355,096Benjamin Izar · Columbia University Health Sciences · U54 · FY2025 · CA
Targeting cellular double-stranded RNA homeostasis in breast cancer
$355,088Cecil Han · Georgetown University · R01 · FY2024 · CA
Project 3: Physical and Metabolic Constraints of Cancer Cell Invasion
$355,046Jan Lammerding · Cornell University · U54 · FY2019 · CA
Osteocytes in prostate cancer bone metastasis
$355,039Evan Todd Keller · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression
$355,032Shannon Michelle Mumenthaler · Ellison Institute, Llc · R01 · FY2022 · CA
Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer
$355,027Deok-Soo Son · Meharry Medical College · SC1 · FY2009 · AI
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$355,019Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2019 · CA
Enhancing anti-EGFR Therapeutic Efficacy in Inflammatory Breast Cancer
$355,019Naoto T Ueno · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma
$355,019Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Tumor-associated neutrophils in human lung cancer
$355,019Evgeniy Eruslanov · University Of Pennsylvania · R01 · FY2019 · CA
p53-Mediated Tumor Immune Surveillance
$355,019David Feldser · University Of Pennsylvania · R01 · FY2019 · CA
SBIR CONCEPT AWARD TO NOVOMEDIX- NOVEL SMALL MOLECULES FOR THE TREATMENT OF RHABDOMYOSARCOMA
$355,000Cathy Swindlehurst · Novomedix, Inc. · N43 · FY2022 · CA
Role of Bone Microenvironment in Tax Induced Malignancies
$354,977Katherine M Weilbaecher · Ohio State University · P01 · FY2011 · CA
Phase I Therapeutic Award: A Novel Engineered Bacterial Anticancer Immunotherapy for Merkel Cell Carcinoma
$354,966Songlee Han · Tranquility Biodesign Llc · N43 · FY2024 · CA
EARLY EVENTS IN MAMMALIAN B CELL DIFFERENTIATION
$354,962Oklahoma Medical Research Foundation · R01 · FY2001 · AI
Reprogramming myeloid cells to inhibit cancer development
$354,961Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Antigen-specific T cells in immunotherapy-associated acute kidney injury
$354,960Naoka Murakami · Brigham And Women'S Hospital · R01 · FY2024 · DK
Exploiting gold nanoparticle as a probe to identify therapeutic targets
$354,959Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA
Project 4: Awakening immune responses to GBM by enhancing immune cell trafficking and activation with oHSV armed with Cetuximab-CCL5 and anti-CD47 antibody payloads.
$354,954Michael A Caligiuri · Brigham And Women'S Hospital · P01 · FY2023 · CA
Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer
$354,880Analisa Virginia Difeo · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
SBIR FY25 CONCEPT AWARD, TARGETING PLOD2 IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
$354,878Syzonc, Llc · N43 · FY2025 · CA
Transmembrane Proteins Involved in Human Tumor Expansion
$354,777James P Quigley · Scripps Research Institute, The · R01 · FY2019 · CA
Mechanisms and Functional Consequences of Selective miRNA transfer via extracellular vesicles
$354,769James G. Patton · Vanderbilt University · P01 · FY2021 · CA
NKG2D superagonist co-stimulation to enhance adaptive immunotherapy of cancer
$354,698Jennifer D Wu · Northwestern University At Chicago · R01 · FY2020 · CA